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Abstract 
We have early identified a family of peptoids that inhibits in vitro the activity of 
the apoptosome, a macromolecular complex that activates mitochondrial-dependent 
apoptosis pathways.  The analysis of peptide-based cell compatible delivery systems of 
the most active peptoid is presented.  Then, the active peptoid was fused to cell 
penetrating peptides (CPP) as penetratin (PEN-peptoid) and HIV-1 TAT (TAT-
peptoid).  PEN-peptoid showed greater cell viability and as a consequence better 
efficiency as apoptosis inhibitor than the TAT-peptoid.  The intracellular trafficking of 
both inhibitors was studied by flow cytometry and confocal fluorescence microscopy.  
Finally, the influence of the cargo (peptoid) molecules on the conformational behavior 
of the CPP in buffers and in membrane mimetic environments was analyzed using 
circular dichroism (CD) spectroscopy. 
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1. Introduction 
Apoptosis, or programmed cell death, is a key cellular mechanism involved in a 
broad range of physiological processes.  Deregulated apoptosis is associated with 
several human pathologies, such as cancer, ischemic injuries and neurological disorders.  
Therefore, there is an increased interest in defining new pharmacological targets that 
could control apoptosis pathways, which in turn would offer new opportunities for the 
discovery and development of drugs [12, 28, 33].  In order to identify molecules that 
could ameliorate disease-associated apoptosis, drug discovery efforts have initially 
targeted caspase activity [10, 32].  However, compensatory mechanisms have been 
described as being able to invoke upon the inhibition of defined caspases [38]; thus, 
mitogenic signals from caspase-inhibited apoptotic cells may contribute to the 
maintenance of tissue homeostasis in healthy tissues and tumor growth under 
pathological conditions [30].  For this reason, the inhibition of cell death upstream of 
caspase activation could be a valuable point of intervention for the development of 
modulators of apoptosis pathways. 
Apoptosome is a holoenzyme multiprotein complex formed by cytochrome c-
activated Apaf-1 (apoptotic protease-activating factor), dATP and procaspase-9 [1, 15].  
In this macromolecular complex, apoptosome-associated caspase-9 is activated, which 
in turn activates effector caspases.  Recent data suggested that the inhibition of the 
apoptosome assembly might represent an interesting target for the development of 
apoptosis modulators [22, 36, 39].  In the absence of detailed structural information, the 
conventional methods used to identify of modulators of apoptosome have been based on 
indirect measurements of the cytochrome c- and dATP-induced activation of caspase-3-
like activity on defined cytosolic extracts [18, 23].  Using this methodology Lademann 
et al. [18] have identified inhibitors of apoptosome through the screening of small 
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molecules using cytosolic extracts of selected cells, whilst Nguyen et al. [23] reported 
the identification of activators.  In a different approach, Malet et al. [21] have identified 
direct Apaf-1 ligands that could be defined as a new structural class of apoptosome 
inhibitors.  From this family of N-alkylglycine inhibitors, the most potent was that 
known as peptoid 1 (scheme 1; Malet et al [21]).  In order to move one step forward, 
structural modifications of this compound had to be done given its poor solubility and 
low membrane permeability.  All efforts performed on peptoid 1 to elongate the peptoid 
chain at either the C- or N-terminus indicated that the chemical diversity attached to the 
nitrogen atoms at the original hit had to be maintained.  In this context, peptoid 1a 
(scheme 1) showed an increased activity in relation to peptoid 1.  However, an initial 
examination of the ability to inhibit apoptosis in intact cells suggested that peptoid 1a 
has a low capacity to cross cellular membranes.  Thus, we further focused our studies on 
delivery systems by means of the use of adequate carriers.  This approach could be 
addressed by the design of hybrid peptide/peptoid conjugates where the parent peptoid 1 
was fused to well characterized cell penetrating peptides (CPPs) [7].  These CPPs are 
polybasic peptides derived from the transduction domains of certain proteins, such as 
penetratin (PEN), which is derived from the sequence of the Drosophila transcription 
factor antennapaedia [25, 35] and a 12-amino acid motif from the HIV-1 Tat protein 
(TAT) [4].  Fusion of a different a cargo either to PEN or TAT peptides has proven to 
be an efficient method for the intracellular delivery of peptides [5, 8], proteins [31], 
antisense oligonucleotides [2] and adenoviruses [11], among others.  Nevertheless, 
differences between TAT and PEN membrane transport capabilities have also been 
observed, mainly due to the influence of the cargo.  Fusion to PEN appears to be 
favored when using proteins with less than 100 residues, whereas TAT has been 
reported to be able to transduce larger molecules, including β- galactosidase (> 1000 
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amino acids) [31].  The carrier efficiency and the influence of the cargo of CPPs fused 
to small molecules have not been analyzed as much [7]. 
In this study we analyzed how the fusion of peptoid 1 to CPPs influence the cell 
membrane permeation capabilities of these carrier peptides as measured by their 
influence on cellular uptake, biological activity of the cargo and the correlation with the 
conformational properties of these molecules in the presence of synthetic lipid 
membranes and membrane mimetics. 
 
2.  Materials and methods 
 
2.1. Peptide and peptide/peptoid hybrids synthesis 
Penetratin (RQIKIWFQNRRMKWKK-NH2) and TAT (YGRKKRRQRRRG-
NH2) control peptides were prepared by Fmoc-based solid phase synthesis on a 433A 
Applied Biosystems Peptide synthesizer.  The hybrids penetratin-GG-peptoid (PEN-
peptoid) and Tat-GG-peptoid (TAT-peptoid) molecules were also synthesized using the 
same procedure but loading the synthesizer with the pre-assembled peptoidyl 1-resin.  
Peptides and conjugates were cleaved from the resin by treatment with trifluoroacetic 
acid (TFA, 70%) and purified by preparative RP-HPLC (Lichrospher® 100 C18, 10 μm) 
using different acetonitrile gradients in aqueous 0.1 % TFA.  The identity and purity 
was confirmed by HPLC and MALDI-TOF mass spectrometry.  Stock solutions of 
control peptides and peptide/peptoid hybrids were prepared in PBS buffer (137 mM 
NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 mM KH2PO4 pH 7.3) and the concentrations 
were determined by UV spectroscopy and quantitative amino acid analysis. 
SCHEME 1 
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2.2. Cell-free caspase activation assays (DEVDase activity) 
A cell free system obtained from human embryonic kidney (HEK) 293 cells was 
used.  This extract was fractioned on a Q-sepharose column that results in a fraction 
(named F1) enriched in endogenous Apaf-1 and a flow-through fraction (named FT) 
that contains cytochrome c and caspases, thus separating the components needed for 
caspase-9/3 activation.  In a typical experiment, recombinant Apaf-1 [21] (rApaf-1; 5-
10 ng) was incubated at 30 ºC by 60 min in the absence or in the presence of inhibitors 
and then combined with a 5 µL aliquot of FT extract, 1 mM dATP and further incubated 
at 37 ºC by 30 min.  Then, a 3 µL aliquot was mixed with 200 µL of caspase assay 
buffer (PBS, 10 % glycerol, 0.1 mM EDTA, 2 mM DTT) containing 20 µM Ac-DEVD-
afc (Biomol).  Caspase activity was continuously monitored following the release of 
fluorescent afc at 37 ºC using a Wallac 1420 Workstation (λexc= 400 nm; λem= 508 nm).  
DEVDase activity was expressed as percentage of the initial fluorescence signal value 
obtained in the absence of inhibitor when the inhibitory activity of compounds was 
evaluated. 
 
2.3. MTT cell viability assays 
An MTT cell viability assay was used to measure cell recovery of U937 human 
histiocytic lymphoma cells and Saos-2 human osteosarcoma cells.  Cells were seeded in 
sterile 96-well microtitre plates at a seeding density of 4x105 and 105 cells/mL, 
respectively and allow settling for 24 h.  Doxycycline (2 μg/mL in PBS) for Saos-2 cells 
and doxorubicin (0.25 μg/mL in PBS) in the case of U937 cells, were then added and 
after 30 min peptide/peptoid 1 hybrids (0.2 μm filter sterilized) were also added to give 
a final concentration of 1-20 μM.  After 19 h incubation time, MTT (20 μL of a 5 
mg/mL solution) was added to each well, and the cells were further incubated for 5 h (a 
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total of 24 h incubation with the inhibitors was therefore studied).  After removal of the 
medium, the precipitated formazan crystals were dissolved in optical grade DMSO (100 
μL), and the plates were read at 570 nm using a Wallac 1420 Workstation. 
 
2.4. Caspase activation assays in cellular models (DEVDase activity). 
Cell extracts were prepared from cells seeded in 3.5 cm plates at  24x105 cells per 
plate for U937.  After different treatments, cells were harvested and the pellets re-
suspended in 30 μL of extraction buffer (50 mM PIPES, 50 mM KCl, 5 mM EDTA, 2 
mM MgCl2, 2 mM DTT supplemented with protease inhibitor cocktail from Sigma) and 
kept on ice 5 min.  After 3 rounds of freeze and thaw, cell lysates were centrifuged for 5 
min at 14000 rpm and supernatants were collected.  Quantification of total protein 
concentration from these cell extracts was performed using the bicinchoninic acid 
method. Aliquots with appropriate protein content were mixed with 200 µL of caspases 
assay buffer (PBS, 10 % glycerol, 0.1 mM EDTA, 2 mM DTT) containing 20 µM Ac-
DEVD-afc.  Caspase activity was continuously monitored following the release of 
fluorescent afc at 30 ºC using a Wallac 1420 Workstation (λexc= 400 nm; λem= 508 nm).  
DEVDase activity was expressed as either as increase of relative fluorescence units per 
min (∆FU/min) or as percentage of the initial fluorescence signal value.  
 
2.5 Cellular internalization studies by flow cytometry and confocal fluorescence 
microscopy. 
 2.5.1. Uptake of PEN-peptoid and TAT-peptoid by U-937 human histiocytic 
lymphoma cells. 
U-937 cells were seeded in 6-well plates at a density of 1 x 106 cells/mL (1 mL 
cell suspension per well) and allowed to settle for 24 h. Carboxyfluoresceine (CF) 
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labeled conjugates (CF-PEN-peptoid and CF-TAT-peptoid, both 1 µM) were added and 
the cells incubated for 0 to 60 min at 37 ºC. At each sample time, cells were placed on 
ice, the cell suspension removed and then centrifuged at 4 ºC (600 x g for 10 min).  The 
cell pellet was re-suspended in ice-chilled PBS (5 mL), this washing procedure was 
repeated three times and finally the cell pellet was re-suspended in ice-chilled PBS (200 
µL) and collected in falcon tubes. Cell-associated fluorescence was then analyzed using 
a Cytomics FC 500 (Beckman Coulter Inc.) equipped with an argon laser (488 nm) and 
emission filter for 530 nm. Data collection involved 25,000 counts per sample and the 
data were analyzed with Beckman Coulter CXP software. Data are expressed by 
plotting the shift in geometric mean of the entire population. Cells incubated without 
polymer conjugate were used to account for the background fluorescence 
 2.5.2. Cellular internalization of PEN-peptoid and TAT-peptoid by Saos-2 
osteosarcoma cells. 
For confocal microscopy internalization studies, Saos-2 cells (1 x 105 cells) were 
seeded in glass bottom culture dishes and left to adhere to the cover slips for 24 h. Cells 
were incubated for either 0, 15, 30 min or 1 h at 37ºC with the CF-peptides (1 μM). 
After this time cells were maintained on ice, washed two times with chilled PBS and 
fixed with paraformaldehyde for 30 min at 37 ºC. Then cells were washed three times 
with PBS and the samples prepared using mounting medium for fluorescence with 
DAPI (Vector Lab. Inc., Burlingame).  Images were captured with a confocal Leica  
microscope equipped with a l-blue 63 x oil immersion objective and handled with a 
TCS SP2 system, equipped with an Acoustic Optical Beam Splitter (AOBS). Excitation 
was with an argon laser (548 nm, 476 nm, 488 nm, 496 nm and 514 nm) and blue diode 
(405 nm). Images were captured at an 8-bit gray scale and processed with LCS software 
(version 2.5.1347a, Leica Germany) containing multicolor, macro and 3D components. 
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For live-cell imaging, Saos-2 cells (1 x 105 cells) were seeded in glass bottom culture 
dishes and left to adhere to the coverslips for 24 h. To assess the subcellular localization 
of the hybrids peptide/peptoid, cells were incubated for either 15, 30 min or 1 h at 37 ºC 
in complete medium (1 mL) containing CF-PEN-peptoid or CF-TAT-peptoid (1 µM). 
Before visualization, medium containing the conjugates was removed from the cells by 
aspiration, and the cells were washed three times with fresh medium (37 ºC). Finally, 
clear complete media was added and cells were subsequently viewed for a maximum of 
30 min. Images were captured with a confocal Leica microscope equipped with a l-blue 
20 x objective and handled with the same system described above. 
 
2.6. Circular dichroism (CD) measurements  
CD spectra were acquired at 5 ºC on a Jasco-810 spectropolarimeter equipped 
with a Peltier temperature control in quartz cells of 0.1 cm path length.  Peptides and 
hybrids were analyzed at 11 μM in all cases.  CD spectra were the average of 20 scans 
made at 0.2 nm intervals, and always the same buffer without peptides, used as baseline, 
was subtracted.  In the model membrane interaction studies, stock solutions of sodium 
dodecyl sulfate (SDS) and 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocoline (LPC) 
were prepared in PBS buffer.  Results are expressed as mean molar residue ellipticities 
[θ]MR (deg cm2/dmol). 
 
3. Results 
3.1. Peptoid derivatives, PEN-peptoid and TAT-peptoid, inhibit Apaf-1 in cell extracts. 
We synthesized hybrid peptide/peptoid molecules where the N-terminus of peptoid 
1, extended with two glycine residues, was fused to CPPs such as penetratin (PEN) and 
Tat HIV-1 (TAT) peptides which yield the compounds PEN-peptoid and TAT-peptoid, 
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respectively (Scheme 1).  Initially, we analyzed how the fusion of peptoid 1 to the PEN 
and TAT peptides could affect its capability as an Apaf-1 inhibitor.  Cytosolic extracts 
of 293 were depleted from endogenous Apaf-1 by chromatography (FT fraction) (see 
the Materials and methods section).  When the recombinant Apaf-1 was pre-incubated 
with peptoid 1a and added to this FT fraction, we observed an inhibition of caspase 
activity as a consequence of the inhibitory activity of peptoid 1a on the apoptosome 
[21].  Using the same procedure, we analyzed the compounds PEN-peptoid and TAT-
peptoid and, a compound concentration-dependent inhibition of the caspase activity was 
found (Figure 1).  We also analyzed the synthetic peptides PEN and TAT as controls, 
and no inhibition was found.  These results suggest that the presence of the CPPs does 
not modify the capability of peptoid 1 to bind to Apaf-1 and, in turn, to inhibit the 
apoptosome-dependent activation of caspases. 
FIGURE 1 
 
3.2. Evaluation of compound cytotoxicity and Apaf-1 inhibitory activity in cellular 
models. 
To evaluate the biological activity of compounds the PEN-peptoid and TAT-
peptoid, U937 human histiocytic lymphoma cells challenged with doxorubicin were 
used.  In this cellular-based model, doxorubicin induces apoptosis through DNA 
damage and this signal is transduced to the mitochondria disturbing the mitochondrial 
membrane potential (MMP) and activating executioner caspases through the 
involvement of apoptosome.  An MTT cell viability assay was initially used to evaluate 
the cellular toxicity of the compounds.  After challenging the cells, MTT was also used 
to determine the prevention of cell-viability loss induced by DNA damage in U937 
cells.  In all cases, the TAT-peptoid showed greater cell toxicity than the PEN-peptoid 
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(Figure 2A), and consequently, less cell-viability recovery after challenging the cells 
(Figure 2B).  It should be noted that treatment with 1 μM PEN-peptoid of U937 cells 
challenged with doxorubicin increased cell survival by 30 percent.  The unspecific cell 
toxicity could preclude the protective effect of the compound at higher PEN-peptoid 
concentrations. 
FIGURE 2 
 
As a more direct indicator of apoptosis cell death, the caspase 3 activity of cells 
treated with the peptoid derivatives (at a concentration of 1 μM) was also analyzed 
using the same cellular model.  A compound time-dependent inhibition of the caspase 
activity was found.  No activity was observed with TAT-peptoid, whereas a caspase 
inhibition of 64 percent was found for the PEN-peptoid at 24 h.  We also analyzed the 
synthetic peptides PEN and TAT as controls, and no inhibition was seen (data not 
shown). 
It is well known that the apoptotic cascade can be triggered through two major 
pathways [16].  Extracellular signals can activate the receptor-mediated extrinsic 
pathway while DNA-damage, hypoxia, loss of survival and other cell stress signals 
trigger the mitochondrial-dependent pathway where the role of both Apaf-1 and 
apoptosome activation has been well established.  Doxorubicin-induced apoptosis has 
been used in different studies [19, 27, 37], and doxorubicin was seen to induce intrinsic 
and extrinsic forms of apoptosis, probably through the implication of mitochondria-
derived reactive oxygen species (ROS) and the modification of cell calcium 
homeostasis [17].  We used Saos-2 cells to obtain a more detailed analysis of the effect 
of the Apaf-1 ligand peptoid 1 and its related compounds in an ‘only intrinsic form’ of 
apoptosis.  In this cell-based model, apoptosis is induced by the conditional expression 
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of Bax through the tet-ON system (Clontech).  Bax is a pro-apoptotic member of the 
Bcl-2 family that induces apoptosis through the liberation of cytochrome c from the 
mitochondria; thus, the activation of apoptosis solely relies in the mitochondrial or 
intrinsic pathway.  In the initial setup experiments with this cell system however, both 
PEN-peptoid and TAT-peptoid hybrids showed non specific cell toxicity, although a 
much smaller inhibitory activity was reached with PEN-peptoid (inhibition of caspase 3 
activity: 64 % vs. 18 % in U-937 and Saos-2 cells at 24 h, respectively). 
 
3.3 Cellular internalization studies. 
In order to prove that the conjugation of our peptoid inhibitor to a CPP enhances 
its cellular internalization, two carboxyfluoresceine (CF) labeled derivatives (CF-PEN-
peptoid and CF-TAT-peptoid) were synthesized to be used as fluorescence probes in 
flow cytometry and confocal fluorescence microscopy studies.  Both conjugates were 
rapidly internalized by the cells in a time-dependent manner (with a plateau after 30 min 
due to fluorescence quenching – Figure 3), as observed by flow cytometry studies.  It 
should be noticed that the TAT-peptoid showed an enhanced membrane binding 
propensity when compare with PEN-peptoid (fluorescence output at t = 0 min - Figure 
3).  Moreover, their preferred internalization mechanism seemed to be different, as seen 
with confocal fluorescence microscopy experiments.  Whereas the PEN-peptoid showed 
a vesicular labeling already after a 15-minute incubation, cells incubated with the TAT-
peptoid showed a cytosolic fluorescence diffusion (Figure 4).  Moreover after a 1-hour 
incubation, the cell damage induced by the TAT-peptoid was much higher than that 
observed with the PEN-peptoid. This data is in good agreement with TAT-peptoid-
observed cytotoxicity. 
FIGURE 3 and FIGURE 4 
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3.4. Structural analysis by CD spectroscopy 
Although PEN and TAT could be initially considered as equally efficient cell 
transporters for a wide variety of cargoes, the cargo could possibly influence any of the 
intrinsic properties of CPPs, having a direct effect on their behavior.  Thus, if the cargo 
modifies the membrane-induced conformational transition capabilities of CPPs, these 
could modify cell permeability.  To explore such a possibility, we analyzed the 
conformational behavior of both the TAT-peptoid and PEN-peptoid in membrane-
mimetic environments and their respective control peptides, TAT and PEN.  The CD 
spectra of PEN, PEN-peptoid, TAT and TAT-peptoid were initially acquired in PBS 
buffer at 5 ºC (Figure 5).  Peptides in aqueous solution tend to be a random coil, which 
is a dynamic structure that changes constantly [13].  In agreement with this statement, 
the spectra of PEN and TAT are representative of a predominantly random structure 
(Figures 5B and 5C, respectivelywhilst a comparison of the CD spectra obtained for the 
PEN-peptoid and the TAT-peptoid suggested an influence of the cargo on the general 
structure of the peptide.  In fact, in the absence of the CD spectrum obtained for the 
PEN-peptoid was representative of a β-sheet conformation and the spectrum for the 
TAT-peptoid was representative of a poly(proline) type II-like conformation with a CD 
spectrum exhibiting a weak positive band at 223 nm and a strong negative band at 196 
nm [9] (Figure 5D).  Trifluoroethanol (TFE) has been used as a solvent additive to 
explore the intrinsic ability of peptides to adopt secondary structure conformations [14].  
TFE titration of PEN and PEN-peptoid solutions resulted in a substantial increase of 
helical content (Figures 5A and 5B), which is in good agreement with previously 
reported data [3].  TFE titration of the TAT peptide also induced the increase in the α-
helix content (Figure 5C).  For the TAT-peptoid however, a TFE-induced 
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conformational transition towards the partial stabilization of a mixed alpha/β secondary 
structure was observed.  This is characterized by a CD spectrum with negative ellipticity 
bands at 220 nm and 205 nm and with marked intensity differences [24] (Figure 5D). 
FIGURE 5 
 
The conformational behavior of all four compounds was also analyzed in the 
presence of both negatively charged (SDS) or zwitterionic (LPC) membrane-mimetic 
environments.  SDS titration of PEN induced a conformational transition towards the 
stabilization of a β-sheet conformation at submicellar (< 3 mM SDS concentration) and 
of an α-helix above the critical micellar concentration (cmc) where SDS forms micellar 
aggregates (Figures 6A).  The PEN-peptoid showed similar trends; however, a SDS-
dependent induction towards helical conformations had already occurred at submicellar 
concentrations.  Above the cmc, the PEN-peptoid adopted a mixed alpha/beta 
conformation with a very intense minimum at 208 nm (Figure 6B).  The TAT peptide 
was induced into a β-sheet conformation at submicellar SDS concentrations (Figure 
6C).  In the presence of micellar concentrations of SDS, the resulting CD spectrum was 
more difficult to analyze due to an increased tendency of the complex to precipitate out 
from the solution.  Nevertheless, the TAT-peptoid could not be analyzed in the presence 
of SDS due to a non specific precipitation. 
FIGURE 6 
 
The conformational behavior of the peptides and peptide/peptoid hybrids was then 
studied using LPC micelles.  As shown in Figures 7A and 7B, both the PEN peptide and 
PEN-peptoid hybrid were induced into an α-helical conformation.  However, both the 
TAT peptide and TAT-peptoid were induced to fold into a PPII-like structure, although 
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the differences in the absolute intensity of the positive ellipticity band at 220 nm and the 
negative ellipticity band at 196 nm suggested differences in the LPC-induced 
conformation (Figures 7C and 7D, respectively). 
FIGURE 7 
 
4. Discussion 
The delivery of identified therapeutics to their site of action at the correct time and 
concentration is a key requirement and a formidable challenge to overcome.  
Unfortunately, despite the promising results shown in vitro, most drugs have 
intracellular trafficking or specificity limitations to achieve the in vivo goal.  Peptoid 1 
was recently developed in our laboratories as a novel apoptosis modulator, showing 
great efficiency as an inhibitor of Apaf-1.  However, structural modifications of this 
lead compound were required to overcome its poor solubility and low membrane 
permeability.  One of the approaches taken was the synthesis of hybrid peptide/peptoid 
molecules where peptoid 1 was fused to the well characterized CPPs, PEN and TAT.  
Unexpected differences in the biological activity of the compounds were observed.  
PEN-peptoid showed greater cell viability and as a consequence better efficiency as an 
apoptosis inhibitor than the TAT-peptoid.  Although both conjugates were internalized 
by the cells in a time-dependent manner as observed by flow cytometry studies, the 
preferred internalization mechanism followed by either hybrid seemed to differ, as seen 
with confocal fluorescence microscopy.  Whereas the PEN-peptoid showed a vesicular 
labeling already after 15 min incubation, cells incubated with the TAT-peptoid showed 
a cytosolic fluorescence diffusion apart from presenting a greater membrane binding.  It 
is tempting to speculate that under our experimental conditions, the preferred 
mechanism of the Saos-2 cells internalization for the PEN-peptoid is endocytosis, 
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whereas the TAT-peptoid shows a preferred traslocation/transduction mechanism.  
Moreover, after an 1-hour incubation, the cell damage induced by the TAT-peptoid was 
much higher than that observed with the PEN-peptoid.  This data is in good agreement 
with the observed TAT-peptoid cytotoxicity. 
The differences observed could be explained by a possible influence of the cargo 
(peptoid 1) on the conformational behavior of the CPP as demonstrated by circular 
dichroism in aqueous solutions and in membrane mimetic environments.  Although it is 
established that the capability of the different CPPs to adopt α-helical conformation is 
not an absolute requirement for internalization [6], it is accepted that different CPPs 
have different internalization mechanisms where the adoption of a defined peptide 
conformation at the aqueous/cell-membrane interface should play an important role [31, 
34].  In fact, the conformational transition from unordered to α-helix was observed for 
both the PEN and PEN-peptoid in the presence of TFE, SDS and LPC micelles.  
However, some differences were observed from the analysis of the conformational 
transition of TAT and TAT-peptoid.  In PBS solution, the control TAT peptide showed 
it could populate a random form while the TAT-peptoid presented PPII helix 
characteristics, indicating a more rigid structure which could explain the greater damage 
in the cell membrane as observed in microscopy studies with the FITC-TAT-peptoid. 
[13, 26].  TFE, which tended to promote secondary conformation transitions, induced an 
α-helix conformation on TAT, while a mixture of alpha/β−sheet secondary structures 
was obtained for the TAT-peptoid.  It is generally accepted that when CPPs seek to 
interact with cell membranes, there is an initial electrostatic interaction, and afterwards, 
the hydrophobic amino acids have a high tendency to be allocated in the hydrophobic 
core.  In some instances such a membrane perturbation would require local membrane 
reorganization probably through a transient formation of mixed peptide/lipid micelles.  
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The formation of such complexes could be analyzed by SDS, a membrane mimetic 
system that allows the study at submicellar and micellar concentrations [20].  
Monomeric SDS induced a conformational change in TAT while precipitation of TAT-
peptoid was observed at all the SDS concentrations analyzed, suggesting a different 
lipid/peptide interaction.  In contrast, irrespective of the initial conformation adopted in 
the buffer solution, both the TAT and TAT-peptoid stabilized a PPII-like conformation 
in the presence of LPC micelles, although a much greater intensity of the minimum at 
196 nm was observed for the TAT-peptoid (Figures 7C and 7D).  These results are in 
partial agreement with those reported by Ruzza et al. [29] on the stabilization of a PPII 
conformation by the peptide TAT.  These authors found that TAT could adopt a PPII 
conformation in a very low ionic strength buffer (Tris-HCl 5 mM, pH 6.8) and in the 
presence of 30 mM SDS, while we found that TAT in PBS buffer (approximately 150 
mM ionic strength) adopted a random conformation and showed a tendency to stabilize 
α-helix, random coil and PPII-like conformations in TFE, SDS and LPC, respectively.  
Differences could arise from the sequence of the TAT peptide used as different regions 
of the TAT protein had already shown a completely different conformational behavior 
[13].  In their studies Ruzza et al. [29] analyzed the sequence GRKKRRQRRRPPQG. 
Conversely, we decided to use a shortened version (YGRKKRRQRRRG-NH2) with 
well demonstrated cell penetrating properties [5], where the aromatic amino acid Tyr 
was included to allow a UV spectroscopy-based determination of peptide concentration 
and the Pro-Pro-Gln C-terminal residues were suppressed to facilitate the synthesis of 
the hybrid TAT-peptoid.   
Nevertheless, the overall results suggest that the biological active conformations 
of both PEN and TAT could be influenced by their cargo even if such a cargo is a small 
molecule, and could result in a loss of the cargo expected biological activity.  
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Collectively, our results contribute to reinforce the observation that the selection of an 
appropriate carrier is a key issue with an important influence on the therapeutic 
efficiency of an identified drug candidate.  
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Legends for scheme  
Scheme 1. Chemical structure of peptoid 1, peptoid 1a and the peptide/peptoid hybrids 
used in this study. 
 
Legends for Figures 
Figure 1. Concentration dependence inhibition of Apaf-1 mediated activation of 
caspases.  The different peptide/peptoid hybrids and peptide controls (x axis) were 
analyzed at 1 μM, 5 μM, 10 μM and 20 μM (black, stripped, grey and white bars, 
respectively). 
 
Figure 2.  Evaluation of biological activity of peptoid 1 analogues.  A.  Cytotoxicity of 
peptoid 1a (), the different peptide/peptoid hybrids (■PEN-peptoid and ● TAT-
peptoid) and peptide controls (□ PEN and | TAT) against U937 cells measured by 
MTT assay after 24 h incubation.  Data expressed as Mean ± SD (n>3).  B.  Evaluation 
of doxorubicin-induced U937 cell death inhibition by peptide/peptoid hybrids and 
peptide controls at different concentrations (1 μM, 5 μM, 10 μM and 20 μM (black, 
stripped, grey and white bars, respectively).  Data expressed as Mean ± SD (n>3). 
 
 
Figure 3. Time-dependent uptake of PEN-peptoid and TAT-peptoid in vitro by U-937 
cells; panel (a) raw data collected after incubation with PEN-peptoid, (b) raw data 
collected after incubation with TAT-peptoid and (c) cell associated fluorescence after 
incubation with PEN-peptoid and TAT-peptoid. Flow cytometry analysis at 37 ºC. The 
values represent mean ± SEM; n ≥ 3.  
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PANELES EN MAYUSCULA Y NEGRITA O MINUSCULA Y 
PARENTESIS???? 
Figure 4. Confocal microscopy live cell images of Saos-2 cells incubated at 37ºC with; 
PEN-peptoid for panel (a)????? 0 min, (b)?????15 min (c)???? 1 h and TAT-peptoide 
for panel (d) 0 min, (e)15 min, (f) 1 h Concentration 1µM. 
 
Figure 5.  Circular dichroism spectra in the presence of different TFE-water mixtures 
(▬0% TFE, □ 20% TFE, Ì 50% TFE, | 100% TFE).  A.  PEN control.  B.  PEN-
peptoid.  C.  TAT control.  D.  TAT-peptoid. 
 
Figure 6.  Circular dichroism spectra in the presence of different concentrations of SDS 
(▬ 0 mM SDS, □ 0.5 mM, Ì1 mM SDS, | 3 mM SDS, ◊ 11 mM SDS).  A.  PEN 
control.  B.  PEN-peptoid.  C.  TAT control. 
 
Figure 7. Circular dichroism spectra in the presence of different concentrations LPC 
micelles (▬  0 μM LPC, □ 100 μM LPC, Ì 400 μM LPC, | 1000 μM LPC).  A.  PEN 
control.  B.  PEN-peptoid.  C.  TAT control.  D.  TAT-peptoid. 
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Scheme 1. Orzáez et al. 
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Figure 1. Orzáez et al. 
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Figure 2. Orzáez et al. 
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Figure 3. Orzáez et al. 
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Figure 4. Orzáez et al. (color Figure) 
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Figure 5. Orzáez et al. 
 
A B
[Θ
]  
de
g
cm
2 d
m
ol
-1
Wavelength (nm) 
C D
-30000
-20000
-10000
0
10000
20000
30000
40000
50000
195 205 215 225 235 245
-15000
-10000
-5000
0
5000
10000
15000
20000
25000
195 205 215 225 235 245
-50000
-40000
-30000
-20000
-10000
0
10000
195 205 215 225 235 245
-25000
-20000
-15000
-10000
-5000
0
5000
10000
15000
20000
195 205 215 225 235 245
[Θ
]  
de
g
cm
2 d
m
ol
-1
 
 
 30
Figure 6. Orzáez et al. 
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Figure 7. Orzáez et al. 
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